Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01877941 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of Cardiac Output Estimation Based on Pulse Wave Transit Time
A NA study of Myocardial Infarction and Myocardial Ischemia, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 39
- Enrollment target
- 2
- Study locations
NCT01877941: Completed NA study of Myocardial Infarction and Myocardial Ischemia, sponsored by University of California, San Francisco.
NCT01877941 is a NA study of Myocardial Infarction and Myocardial Ischemia that has completed, run by University of California, San Francisco. The registered enrollment target is 39 participants, below the 4,681-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01877941, a NA study of Myocardial Infarction and Myocardial Ischemia, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
- 2
- Study locations
Study Summary
The specific aim of this study is to assess whether a device approved by the FDA to measure pulse oximetry can accurately estimate cardiac output.
Primary Outcome
6 Measurements of cardiac output derived from pulse oximeter measurements using the esCCO system were taken at each time point. The measurements deemed valid under the criteria in the protocol were averaged to represent the reference value at that point. The mean and standard deviation reported consist of the reference values from all time points measured. Data for this test were taken at the following timepoints: 1\. Start of Sterenotomy; 2. Before Bypass; 3. 30 Min after bypass; 4. Closure;
Conditions Studied
Interventions
- DEVICE Pulmonary Artery Catheter (PAC)
- DEVICE Endotracheal Cardiac Output Monitor (ECOM)
- DEVICE Estimated Continuous Cardiac Output (esCCO)
Study Locations (2)
California
- San Francisco VA Medical Center - San Francisco
Pennsylvania
- Drexel University - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2012-12 |
| Est. Completion | 2013-12 |
| Phase | NA |
What the finished NCT01877941 record still lists
NCT01877941 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 39 participants, a relatively small participant target, below the 4,681-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Myocardial Infarction appearing as the primary indexed condition, and to 3 interventions - of which Pulmonary Artery Catheter (PAC) is the first listed.
NCT01877941 reports a single indexed study location in California, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01877941 about?
NCT01877941 is a clinical study titled "Clinical Evaluation of Cardiac Output Estimation Based on Pulse Wave Transit Time". The specific aim of this study is to assess whether a device approved by the FDA to measure pulse oximetry can accurately estimate cardiac output.
What is the current status of trial NCT01877941?
This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2012-12. Estimated completion is 2013-12.
What conditions does trial NCT01877941 study?
This clinical trial studies the following conditions: Myocardial Infarction, Myocardial Ischemia.
What interventions are being tested in trial NCT01877941?
The interventions under investigation include: Pulmonary Artery Catheter (PAC) (DEVICE), Endotracheal Cardiac Output Monitor (ECOM) (DEVICE), Estimated Continuous Cardiac Output (esCCO) (DEVICE).
Who is sponsoring clinical trial NCT01877941?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01877941 being conducted?
This trial has 2 study locations across California, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myocardial Infarction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01877941's enrollment target sits among peer trials
39 61st of 64 higher than 4 of 64 other Myocardial Infarction trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myocardial Infarction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
RECRUITING · NA
-
Women's Heart Attack Research Program: Stress Ancillary Study
RECRUITING · NA
-
Cardiac Radioablation for VT
RECRUITING · NA
-
Examination of the Impact of CalmiGo's Stress Management Device on Vascular Heath and Cardiovascular Disease Risk.
RECRUITING · NA
-
Reducing Blood Pressure in Patients With High Cardiovascular Risk
RECRUITING · NA
-
Influence of Pulse Electromagnetic Field Therapy on Myocardial Ischemia
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia